Skip to main content
Dr Mel Spigelman

Mel Spigelman, MD, President and CEO of TB Alliance

Dr. Spigelman is the President and Chief Executive Officer of the Global Alliance for TB Drug Development (TB Alliance), and a Member of its Board of Directors. He is regarded as one of the world’s leading experts in tuberculosis and TB drug development.

On World TB Day, new clinical trials offer hope against drug-resistant TB

Posted by: , Posted on: - Categories: Development Debates, Health
DFID has been visionary in supporting a wave of clinical trials, which can help provide the tools to tackle drug-resistant TB.

In advance of World TB Day, a global clinical trial has begun to test a new regimen for tuberculosis (TB), which shows particular promise for improving treatment of multidrug-resistant TB (MDR-TB). The trial will be conducted at 50 sites in …